ArticleProteomics2021

SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: An in-silico proof-of-principle of proteomics-based drug repurposing.

Agnieszka Latosinska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.